Buscar





Buscar





Mercado
/
Acciones
/
nasdaq-neo
/

Neogenomics Inc

NEO

Añadir a la lista de seguimiento

8.240USD

-0.120-1.44%

Cierre 05/15, 16:00（ET）Cotizaciones retrasadas 15 min

1.07BCap. mercado

PérdidaP/E TTM



Neogenomics Inc

8.240

-0.120-1.44%

Descripción general Finanzas Discusiones Análisis Compañía

Descripción general

Finanzas

Discusiones

Análisis

Compañía

Más Datos de Neogenomics Inc Compañía

NeoGenomics, Inc. is a cancer diagnostics company specializing in cancer genetics testing and information services. The Company offers comprehensive oncology-focused testing menus across the cancer continuum, serving oncologists, pathologists, hospital systems, academic centers, and pharmaceutical firms with diagnostic and predictive testing to help them diagnose and treat cancer. Its services include clinical cancer testing; interpretation and consultative services; molecular and NGS testing; comprehensive technical and professional services offering; clinical trials and research; validation laboratory services, and oncology data solutions. It operates a network of laboratories for full-service sample processing and analysis services throughout the United States and a full-service sample-processing laboratory in Cambridge, United Kingdom. Its testing services include Cytogenetics (karyotype analysis), Fluorescence In-Situ Hybridization (FISH), Flow cytometry, and others.

Información de Neogenomics Inc



Símbolo de cotizaciónNEO

Nombre de la empresaNeogenomics Inc

Fecha de salida a bolsaDec 10, 2012

Director ejecutivoZook (Antony P)

Número de empleados2200

Tipo de seguridadOrdinary Share

Fin del año fiscalDec 10

Dirección9490 Neogenomics Way

CiudadFORT MYERS

Bolsa de valoresNASDAQ OMX - NASDAQ BASIC

PaísUnited States of America

Código postal33912

Teléfono12397680600

Sitio Webhttps://neogenomics.com/

Símbolo de cotizaciónNEO

Fecha de salida a bolsaDec 10, 2012

Director ejecutivoZook (Antony P)

Ejecutivos de Neogenomics Inc



Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

220.01K

+0.96%

Mr. Warren Stone

President, Chief Operating Officer

161.99K

+2.23%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

Dr. Neil Gunn

Independent Director

28.10K

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

Dr. Alison L. Hannah, M.D.

Independent Director

Mr. Michael A. Kelly

Lead Independent Director

Mr. David B. Perez

Independent Director

Ms. Alicia Olivo

Executive Vice President, General Counsel & Business Development

Nombre

Nombre/Posición

Posición

Accionistas

Cambio

Mr. Jeffrey Scott (Jeff) Sherman

Chief Financial Officer

220.01K

+0.96%

Mr. Warren Stone

President, Chief Operating Officer

161.99K

+2.23%

Mr. Stephen Michael Kanovsky

Independent Director

52.34K

Dr. Neil Gunn

Independent Director

28.10K

Ms. Felicia Williams

Independent Director

7.16K

Ms. Lynn A. Tetrault, J.D.

Independent Chairman of the Board

Desglose de ingresos

Divisa: USDActualizado: lun., 6 de abr

FY2025

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022

FY2022Q4

FY2022Q3

FY2022Q2

FY2021

FY2020

FY2019

Por negocioUSD

Nombre

Ganancia

Proporción

Clinical Services-Client direct billing

518.84M

71.34%

Clinical Services-Commercial Insurance

117.51M

16.16%

Clinical Services-Medicare and Medicaid

90.87M

12.49%

Clinical Services-Self-Pay

114.00K

0.02%

La empresa aún no ha revelado los datos relevantes.

Por negocio

Por región

Por negocioUSD

Nombre

Ganancia

Proporción

Clinical Services-Client direct billing

518.84M

71.34%

Clinical Services-Commercial Insurance

117.51M

16.16%

Clinical Services-Medicare and Medicaid

90.87M

12.49%

Clinical Services-Self-Pay

114.00K

0.02%

Estadísticas de accionistas

Actualizado: dom., 10 de may

Accionistas

Tipos de accionistas

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.61%

First Light Asset Management, LLC

10.47%

First Trust Advisors L.P.

7.54%

Greenhouse Funds LLLP

6.64%

Vanguard Portfolio Management, LLC

5.85%

Otro

55.89%

Accionistas

Proporción

BlackRock Institutional Trust Company, N.A.

13.61%

First Light Asset Management, LLC

10.47%

First Trust Advisors L.P.

7.54%

Greenhouse Funds LLLP

6.64%

Vanguard Portfolio Management, LLC

5.85%

Otro

55.89%

Tipos de accionistas

Accionistas

Proporción

Investment Advisor

50.65%

Investment Advisor/Hedge Fund

34.43%

Hedge Fund

23.70%

Research Firm

1.98%

Individual Investor

1.93%

Pension Fund

1.20%

Bank and Trust

0.61%

Family Office

0.03%

Insurance Company

0.03%

Participación institucional



Actualizado: mié., 1 de abr

Periodo del informe

Número de instituciones

Acciones mantenidas

Proporción

Cambio

2026Q1

564

156.61M

120.32%

+7.52M

2025Q4

573

134.55M

103.99%

-8.37M

2025Q3

568

127.88M

98.83%

-9.78M

2025Q2

571

126.82M

98.17%

-12.95M

2025Q1

596

131.44M

102.13%

-4.71M

2024Q4

585

127.59M

99.32%

-7.82M

2024Q3

589

129.38M

100.96%

-8.76M

2024Q2

597

131.21M

102.74%

-9.36M

2024Q1

633

132.83M

104.04%

-13.13M

2023Q4

672

130.90M

102.70%

-12.18M

Actividad de los accionistas



Nombre

Acciones mantenidas

Proporción

Cambio

Cambio %

Fecha

BlackRock Institutional Trust Company, N.A.

17.72M

13.65%

+137.81K

+0.78%

Dec 31, 2025

First Light Asset Management, LLC

10.04M

7.73%

+107.79K

+1.09%

Dec 31, 2025

First Trust Advisors L.P.

6.22M

4.79%

+87.61K

+1.43%

Feb 28, 2026

Greenhouse Funds LLLP

8.64M

6.66%

+423.19K

+5.15%

Dec 31, 2025

D. E. Shaw & Co., L.P.

5.30M

4.08%

+2.00M

+60.66%

Dec 31, 2025

Millennium Management LLC

5.20M

4.01%

-1.23M

-19.15%

Dec 31, 2025

State Street Investment Management (US)

4.98M

3.83%

-43.96K

-0.88%

Dec 31, 2025

Braidwell LP

4.63M

3.57%

+2.86M

+161.57%

Dec 31, 2025

ETFs relacionados



Actualizado: sáb., 6 de dic

Nombre

Proporción

State Street SPDR S&P Health Care Services ETF

2.38%

Invesco S&P SmallCap Health Care ETF

0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

0.5%

Inspire Small/Mid Cap ESG ETF

0.32%

iShares U.S. Healthcare Providers ETF

0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

0.14%

iShares S&P Small-Cap 600 Value ETF

0.12%

Nuveen ESG Small-Cap ETF

0.11%

iShares ESG Select Screened S&P Small-Cap ETF

0.1%

iShares Core S&P Small-Cap ETF

0.09%

State Street SPDR S&P Health Care Services ETF

Proporción2.38%

Invesco S&P SmallCap Health Care ETF

Proporción0.77%

First Trust Nasdaq Lux Digi Health Solutions ETF

Proporción0.5%

Inspire Small/Mid Cap ESG ETF

Proporción0.32%

iShares U.S. Healthcare Providers ETF

Proporción0.2%

Invesco S&P SmallCap 600 QVM Multi-factor ETF

Proporción0.14%

iShares S&P Small-Cap 600 Value ETF

Proporción0.12%

Nuveen ESG Small-Cap ETF

Proporción0.11%

iShares ESG Select Screened S&P Small-Cap ETF

Proporción0.1%

iShares Core S&P Small-Cap ETF

Proporción0.09%

Dividendos



Un total de 0.00 USD se ha distribuido en dividendos durante los últimos 5 años.

Fecha

Dividendos

Fecha de registro

Fecha de pago

Fecha ex-dividendo

Sin datos

División de acciones



Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

Fecha

Fecha ex-dividendo

Tipo

Relación

Sin datos

KeyAI

